Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Muscular dystrophy meets protein biochemistry, the mother of invention
Steven D. Funk, Jeffrey H. Miner
Steven D. Funk, Jeffrey H. Miner
Published February 20, 2017
Citation Information: J Clin Invest. 2017;127(3):798-800. https://doi.org/10.1172/JCI92847.
View: Text | PDF
Commentary

Muscular dystrophy meets protein biochemistry, the mother of invention

  • Text
  • PDF
Abstract

Muscular dystrophies result from a defect in the linkage between the muscle fiber cytoskeleton and the basement membrane (BM). Congenital muscular dystrophy type MDC1A is caused by mutations in laminin α2 that either reduce its expression or impair its ability to polymerize within the muscle fiber BM. Defects in this BM lead to muscle fiber damage from the force of contraction. In this issue of the JCI, McKee and colleagues use a laminin polymerization–competent, designer chimeric BM protein in vivo to restore function of a polymerization-defective laminin, leading to normalized muscle structure and strength in a mouse model of MDC1A. Delivery of such a protein to patients could ameliorate many aspects of their disease.

Authors

Steven D. Funk, Jeffrey H. Miner

×

Figure 1

A designer chimeric polypeptide restores function of defective laminin.

Options: View larger image (or click on image) Download as PowerPoint
A designer chimeric polypeptide restores function of defective laminin.
...
Lm211 is a heterotrimeric glycoprotein consisting of one α2-, one β1-, and one γ1-subunit that is an essential extracellular matrix component of the skeletal muscle fiber BM. WT Lm211 readily polymerizes and becomes integrated into the BM and serves to link the muscle fiber to the BM via receptor binding. Mutations in the gene encoding the laminin α2-subunit cause a congenital muscular dystrophy due to absent or defective Lm211. The mutant Lm211 present in dy2J/dy2J mice has a truncated laminin α2 that is unable to polymerize. The polymerization defect results in disruption of the BM, leading to loss of BM integrity and reduced muscle function. In this issue, McKee and colleagues developed a chimeric polypeptide (αLNNd) that contains the laminin N-terminal (LN) domain of the laminin α1-subunit and the G2-G3 domains of nidogen, which simultaneously rescued polymerization of mutant truncated laminin α2/Lm211 (right) and linked laminin to the collagen IV network (not depicted). αLNNd thereby restored muscle function in dy2J/dy2J mice.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts